Medicare funding for TMS

Recently, Medicare funding has become available for TMS, for those with depression that has not responded to antidepressant medications or psychotherapy. Medicare funding reduces out-of-pocket costs and can benefit thousands of Australians each year needing access to alternative care for treatment-resistant depression.

Transcranial Magnetic Stimulation

TMS for the treatment of depression & OCD

Up to one half of people with depression either do not respond to antidepressant medications or make the decision to discontinue medication due to side effects. At neurocare we offer a medication free alternative for treating mood disorders like depression and OCD, Transcranial Magnetic Stimulation (TMS).

Who can benefit from TMS?

  • Individuals diagnosed with depression
  • Individuals diagnosed with treatment-resistant depression (depression that has not responded to psychotherapy and/or medication)
  • Individuals diagnosed with OCD
  • Individuals who wish to taper or cease medication for depression or OCD and are looking for therapy to support that process.

What is TMS?

TMS as an intervention for depression and OCD has been widely researched for over 30 years. TMS works by delivering magnetic pulses to alter the activity within the brain networks that regulate our mood. The stimulation is delivered by a coil placed over the forehead. TMS is painless and free of any side effects. Because this method of stimulation is light and focused, TMS has no negative effects on thinking, memory and normal brain functions.

The neurocare approach combines TMS with psychotherapy. This approach maximises the brain’s natural ability for change and recovery. Sessions are held at least twice per week with 20– 30 sessions typically needed to consolidate antidepressant effects.

With our combined approach, over two-thirds of individuals experience long-term positive effects*. This makes TMS an effective and fast-working treatment program for those looking for an alternative to medication

Frequently Asked Questions about TMS

The advantage of combining TMS with Psychotherapy

In 2017 a study looked at treatment of 196 patients receiving Magnetic Stimulation combined with Psychotherapy at neuroCare Clinics in The Netherlands and found that by combining the two techniques, the patient is more likely achieve remission from Depression. After an average of 21 sessions66% of patients with Treatment Resistant Depression responded well to the combined approach, with lasting effects after 6 months in 65% of this group.

Source: Donse et al. (2017) Simultaneous rTMS and Psychotherapy in Major Depressive Disorder: Clinical Outcomes and Predictors from a Large Naturalistic Study. Brain Stimulation.


66% Efficacy

TMS, when combined with Psychotherapy, is proven to be effective in 66% of patients with Treatment Resistant Depression (Donse et al. 2017)

A short-term treatment Program

TMS is administered at least two times per week and studies show that after an average of 20 sessions, depressive symptoms decrease for the long-term

Medication Free

TMS is particularly suited to and recommended for those who do not respond to traditional medication management for Depression

Minimal Side-effects

TMS has the advantage of not inducing side-effects common with anti-depressant medications

Are you considering TMS for you or a loved one?

We offer TMS across Sydney and Melbourne

Call 1300 149 300

Want to learn more about this program or our assessments?

Please write to us below, briefly telling us about your situation and how you think we may be able to help.

We integrate leading research, digital therapeutics, physical devices, clinics, and professional education to offer the most comprehensive mental health solutions to patients, therapists and the research community.

Visit our global website

neuroCademy Professional Training & Science



SPA Member Logo    

Copyright neurocare Group Pty Ltd. 2021. All rights reserved.